Synexus Clinical Research US Inc.-Chicago — Chicago, Illinois

Synexus Clinical Research US Inc.-Chicago is a clinical research site located in Chicago, Illinois, United States 60602.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Synexus Clinical Research US Inc.-Chicago has participated in 6 clinical trials with 1 currently active.

Therapeutic areas: Pro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene Mutations, Irritable Bowel Syndrome With Diarrhea, Seasonal Influenza.

Sponsors: Rhythm Pharmaceuticals, Inc., OrphoMed, Inc., ModernaTX, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

• The University of Chicago Medicine Duchossois Center for Advanced Medicine
• Jeffrey Kramer, MDSC at Mercy Hospital
• University Consultants in Allergry and Immunology
• Rush University Med Ctr
• University of Illinois Medical Center in Chicago
• University of Chicago Medical Center (UCMC) Center for Advanced Medicine (CAM)
• Rush University Medical Center-Orthopedic Spine
• Northestern University
• University of Chicao
• Rush University Medical Center - Department Of Cardiology
• Northwestern University Diagnostic Testing Center
• University of Illinois Chicago

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Synexus Clinical Research US Inc.-Chicago?

Synexus Clinical Research US Inc.-Chicago has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Synexus Clinical Research US Inc.-Chicago conducted?

Synexus Clinical Research US Inc.-Chicago has 6 clinical trials on record, with 1 currently active. Their work covers Pro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene Mutations, Irritable Bowel Syndrome With Diarrhea, Seasonal Influenza.

Is Synexus Clinical Research US Inc.-Chicago accredited by Crixeo Clinical Trials?

Synexus Clinical Research US Inc.-Chicago has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Synexus Clinical Research US Inc.-Chicago?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.